{
  "docId": "019de515-46e8-778b-9aa2-edc9d4857990",
  "docSlug": "9b80ae10198fa4f452f4044732defb94",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 17 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 17,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-46e8-778b-9aa2-edc9d4857990/3",
  "deckHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990",
  "deckJsonHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990.json",
  "deckAnchorHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.039,
        "w": 0.15,
        "x": 0.808,
        "y": 0.057
      },
      "kind": "image",
      "text": "MMaxCyte",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d2d17f38-8a2e-407a-95e3-7fa5b4f9c019",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.337,
        "w": 0.29,
        "x": 0.036,
        "y": 0.47
      },
      "kind": "list",
      "text": "Enables delivery of almost any molecule into almost any cell type\nLeads the industry in performance (measured by consistency, efficiency, viability, flexibility and scale)\nExtensive product portfolio, supported by a robust intellectual property portfolio\n~25% 5-Year CAGR of core revenue growth (2018-2022); pharmaceutical-like gross margins of ~89% (2018-2021)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12047b81-70fe-4902-86fb-319aff08fd73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.159,
        "w": 0.305,
        "x": 0.02,
        "y": 0.194
      },
      "kind": "list",
      "text": "With 600+ platforms in place, our proprietary technology unlocks the significant potential of advanced therapeutics",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5180ca8f-2a51-443f-ab62-2c400e30da02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.297,
        "w": 0.29,
        "x": 0.68,
        "y": 0.47
      },
      "kind": "list",
      "text": "Allows MaxCyte to participate in the value created by our partners' programs\n19 SPL partnerships, which include over $1.55B** in potential pre-commercial milestone payments with upside from commercial sales-based payments\nFocused over the long-term on creating a diverse portfolio of patient treatments for indications developed by our strategic partners",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62f8dcf8-9aae-4d8d-b502-d2251b842392",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.106,
        "w": 0.305,
        "x": 0.664,
        "y": 0.194
      },
      "kind": "list",
      "text": "Innovative business model focused on value creation and shared partnership success",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a96dfb7-14e0-4a93-bb9e-cd5838641470",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.364,
        "w": 0.29,
        "x": 0.358,
        "y": 0.47
      },
      "kind": "list",
      "text": "20+ years of cell engineering expertise; 25+ field sales and application scientists that support our customers*\nSignificant number of collaborations with industry and academia\nFDA Master File and International Technical Files provide clear regulatory path, potentially reducing clinical risk/shortening clinical development\nUsed to manufacture drug products for over 45 clinical trials to date",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9216dc8d-6342-4c63-afad-dfd568262e8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.159,
        "w": 0.305,
        "x": 0.342,
        "y": 0.194
      },
      "kind": "list",
      "text": "Leading the growing next-generation cell therapy market and capitalizing on rising demand for non-viral engineering approaches",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5cc1ae1-6661-4bb0-a09a-a7dafa87b0f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.014,
        "w": 0.007,
        "x": 0.496,
        "y": 0.96
      },
      "kind": "other",
      "text": "3",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "171aa1c7-615c-4465-994c-874be3a1873b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.014,
        "w": 0.156,
        "x": 0.822,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06f8ddd6-5d77-4fec-b966-4d310b0a1de0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.014,
        "w": 0.13,
        "x": 0.7,
        "y": 0.875
      },
      "kind": "source-note",
      "text": "**As of December 2022",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ca89bff-b7d5-4a42-81db-c52f9a794da4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.014,
        "w": 0.129,
        "x": 0.358,
        "y": 0.875
      },
      "kind": "source-note",
      "text": "*As of September 2022",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d13247f6-3e7f-4f9d-a4f3-6b923e152a68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.74,
        "x": 0.042,
        "y": 0.06
      },
      "kind": "title",
      "text": "A Leading Provider of Cell-Engineering Platform Technologies",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6139c0f2-52f3-4afb-925d-96d4e4a4495b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "edf681b3-a369-496a-b52f-d35917f6be6d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is introduced on page 3",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}